FDA approves first orally administered botanical drug

Related tags Pharmacology

FDA approves first orally administered botanical drug
For the first time, FDA has approved an orally administered botanical as a new drug, the American Botanical Council reports.

On Dec. 31 the agency approved crofelemer, under the brand name of Fulyzag from Raleigh, NC-based Salix Pharmaceuticals Ltd, for use in treating HIV-related diarrhea. In 2006 the agency had approved as a drug a topical containing green tea.

Crofelemer is derived from the latex of the South American sangre de drago tree (dragon's blood, Croton lechleri). A red, blood-resembling latex leaks from the tree when its bark is cut, and it is this substance that contains the novel polymolecular structure crofelemer, originally developed and standardized by Shaman Pharmaceuticals.

According to FDA, in a trial of 374 HIV-positive participants, 17.6% showed a positive clinical response with the new drug as opposed to 8% in the placebo group.

Salix says it plans to have the drug available for prescription in early 2013. According to ABC, a Bloomberg analysis predicts sales of the drug of of $18 million in 2013 and $26 million in 2014.

Related news

Show more

Related products

show more

A Groundbreaking Prebiotic

A Groundbreaking Prebiotic

Content provided by ADM | 12-Mar-2024 | Infographic

PreforPro® is a clinically studied prebiotic that supports the growth of select beneficial bacteria in the gut by utilizing phage technology.

MOROSIL:INGREDIENT OF THE YEAR

MOROSIL:INGREDIENT OF THE YEAR

Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 07-Mar-2024 | Product Brochure

MOROSIL™ has won as Ingredient of the Year in the category Weight Management at 2023 Nutraingredient USA. MOROSIL ™ is a standardized extract derived from...

Consumers' growing demand for Omegas

Consumers' growing demand for Omegas

Content provided by Fruit d'Or | 13-Feb-2024 | White Paper

Consumers are increasingly interested in the benefits of omegas supplements. According to forecasts for 2023–2030, the global omega-3 market is expected...

Curcumin may support cognitive, brain & mood benefits

Curcumin may support cognitive, brain & mood benefits

Content provided by Verdure Sciences | 02-Feb-2024 | White Paper

Cognitive health, mental acuity and brain support categories have seen tremendous growth. With an aging population and increased interest from formulators...

Related suppliers

Follow us

Products

View more

Webinars